Cadwell Laboratories, Inc.
Cadwell Laboratories, Inc., headquartered in the United States, is a leading innovator in the medical device industry, specialising in neurodiagnostic and neuromonitoring solutions. Founded in 1979, the company has established a strong presence in key operational regions across North America and beyond, consistently delivering advanced technologies that enhance patient care. Cadwell's core products include electroencephalography (EEG) systems, electromyography (EMG) devices, and sleep diagnostic equipment, all designed with a focus on precision and user-friendliness. The company is recognised for its commitment to quality and innovation, positioning itself as a trusted partner in the healthcare sector. With numerous accolades and a reputation for excellence, Cadwell Laboratories continues to shape the future of neurodiagnostic practices worldwide.
DitchCarbon Score
How does Cadwell Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cadwell Laboratories, Inc.'s score of 31 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cadwell Laboratories, Inc.'s reported carbon emissions
In 2023, Cadwell Laboratories, Inc. reported total carbon emissions of approximately 15,400,000,000 kg CO2e from Scope 1 and 3,200,000,000 kg CO2e from Scope 2 (market-based), resulting in a combined total of about 18,600,000,000 kg CO2e for Scope 1 and 2 emissions. This reflects a slight increase from 2022, where emissions were about 14,800,000,000 kg CO2e for Scope 1 and the same Scope 2 figures. Cadwell Laboratories has set ambitious climate commitments, aiming for net zero emissions by 2050 for both Scope 1 and Scope 2 emissions. This long-term target was established in 2023, demonstrating the company's commitment to reducing its carbon footprint significantly over the coming decades. The company has not disclosed any Scope 3 emissions data, which typically includes indirect emissions from the supply chain and product use. However, the focus on achieving net zero for direct and indirect emissions highlights Cadwell's proactive approach to climate action within its operational framework.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 15,200,000,000 | 00,000,000,000 | 00,000,000,000 |
| Scope 2 | 3,100,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cadwell Laboratories, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
